FYERS
Choksi Laboratories191.00
-0.30 (-0.16%)

Choksi Laboratories Share Price

191.00-0.30 (-0.16%)
-2.23% past 1 Year

Corporate filings & documents

Announcements

Board of Director in the board meeting dated 19.09.2026 has approved the issuance and allotment of warrants convertible into shares to promoter subject to approval from shareholders.
3 days ago
Board of Director in the board meeting dated 19.09.2026 has approved the issuance and allotment of warrants convertible into shares to promoter subject to approval from shareholders.
3 days ago
The voting result along with scrutinizer report for the AGM held on 18.09.2026
3 days ago
The voting result along with scrutinizer report for the AGM held on 18.09.2026
3 days ago
1. Issuance and allotment of upto 3 50 000 (Three Lakh Fifty Thousand) warrants fully convertible into one fully paid-up equity share of the Company to the Persons belonging to Promoter and Promoter Group on preferential basis in terms of Chapter V of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations 2018 (the ICDR Regulations) as amended Companies Act 2013 and other applicable laws at price of Rs. 177/- (Rupees One Hundred Seventy-Seven Only) per warrant (being the price not less than the minimum price determined with reference to the Relevant Date i.e. September 17 2026 in accordance with Regulation 165 of the ICDR Regulations) aggregating upto maximum amount of Rs. 6 19 50 000 (Rupees Six Crores Nineteen Lakhs Fifty Thousand Only). Other matters as attached
3 days ago
1. Issuance and allotment of upto 3 50 000 (Three Lakh Fifty Thousand) warrants fully convertible into one fully paid-up equity share of the Company to the Persons belonging to Promoter and Promoter Group on preferential basis in terms of Chapter V of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations 2018 (the ICDR Regulations) as amended Companies Act 2013 and other applicable laws at price of Rs. 177/- (Rupees One Hundred Seventy-Seven Only) per warrant (being the price not less than the minimum price determined with reference to the Relevant Date i.e. September 17 2026 in accordance with Regulation 165 of the ICDR Regulations) aggregating upto maximum amount of Rs. 6 19 50 000 (Rupees Six Crores Nineteen Lakhs Fifty Thousand Only). Other matters as attached
3 days ago
Proceedings of the 33rd Annual General Meeting held on 18.09.2026
4 days ago
Proceedings of the 33rd Annual General Meeting held on 18.09.2026
4 days ago
Choksi Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/09/2026 inter alia to consider and approve 1. To consider and approve the proposal for raising funds through issue of equity shares and/ or any other equity-linked or convertible securities including warrants through preferential issue and/ or any other permissible mode(s) in accordance with the Companies Act 2013 the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirement) Regulations 2018 as amended and all other applicable laws as may be considered appropriate subject to the approval of the members of the Company and such other statutory or regulatory approvals as may be applicable.;2. Any other item may be taken up for consideration with the permission of the Chairman and with the consent of a majority of the Directors present in the Meeting which shall include at least one independent Director. If any
1 week ago
Choksi Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/09/2026 inter alia to consider and approve 1. To consider and approve the proposal for raising funds through issue of equity shares and/ or any other equity-linked or convertible securities including warrants through preferential issue and/ or any other permissible mode(s) in accordance with the Companies Act 2013 the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirement) Regulations 2018 as amended and all other applicable laws as may be considered appropriate subject to the approval of the members of the Company and such other statutory or regulatory approvals as may be applicable.;2. Any other item may be taken up for consideration with the permission of the Chairman and with the consent of a majority of the Directors present in the Meeting which shall include at least one independent Director. If any
1 week ago
Submission of newspaper clipping for the Notice of 33rd Annual General Meeting of the company
3 weeks ago
Submission of newspaper clipping for the Notice of 33rd Annual General Meeting of the company
3 weeks ago
Submission of intimation for dispatch of letter regarding notice of upcoming AGM to those shareholders whose email addresses are not registered with the company/RTA or depositories
3 weeks ago
Submission of intimation for dispatch of letter regarding notice of upcoming AGM to those shareholders whose email addresses are not registered with the company/RTA or depositories
3 weeks ago
Submission of Annual Report for the F.Y. 2025-26
4 weeks ago
Submission of Annual Report for the F.Y. 2025-26
4 weeks ago
Submission of Notice convening 33rd AGM of the company to be held on 18th September 2026 at 12:30 p.m. through Video conference/Other Audio Visual means
4 weeks ago
Submission of Notice convening 33rd AGM of the company to be held on 18th September 2026 at 12:30 p.m. through Video conference/Other Audio Visual means
4 weeks ago
Intimation under Regulation 30 of SEBI (LODR) 2015 for inspection of USFDA
1 month ago
Intimation under Regulation 30 of SEBI (LODR) 2015 for inspection of USFDA
1 month ago
Submission of newspaper clipping of information regarding 33rd Annual General Meeting of the company
1 month ago
Submission of newspaper clipping of information regarding 33rd Annual General Meeting of the company
1 month ago
Newspaper publication of unaudited financial result for the quarter ended 30th June 2026
1 month ago
Newspaper publication of unaudited financial result for the quarter ended 30th June 2026
1 month ago
Reappointment of Internal Auditor for the F.Y. 2026-27
1 month ago
Reappointment of Internal Auditor for the F.Y. 2026-27
1 month ago
Reappointment of Ms. Himika Choksi as Whole Time Director for further period of five year w.e.f 01.04.2027 subject to approval from shareholders in the ensuing AGM.
1 month ago
Reappointment of Ms. Himika Choksi as Whole Time Director for further period of five year w.e.f 01.04.2027 subject to approval from shareholders in the ensuing AGM.
1 month ago
Considered and approved the unaudited financial results of the company for the quarter ended 30th June. 2026
1 month ago
Considered and approved the unaudited financial results of the company for the quarter ended 30th June. 2026
1 month ago
1. Considered and approved the Unaudited Financial Results for the Quarter ended on 30th June 2026 along with the Limited review report;2. Decided the date for closure of Register of Members and share transfer Books of the Company from Saturday 12th September 2026 to Friday 18th September 2026 (both days inclusive) for the purpose of 33rd Annual General Meeting;3. The Board has also discussed the other operational financial and administrative matters in detail and passed the necessary resolution.
1 month ago
1. Considered and approved the Unaudited Financial Results for the Quarter ended on 30th June 2026 along with the Limited review report;2. Decided the date for closure of Register of Members and share transfer Books of the Company from Saturday 12th September 2026 to Friday 18th September 2026 (both days inclusive) for the purpose of 33rd Annual General Meeting;3. The Board has also discussed the other operational financial and administrative matters in detail and passed the necessary resolution.
1 month ago
Choksi Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve 1. To consider and approve the Unaudited Financial Result of the Company for the Quarter ended on 30th June 2026;2. To consider the appointment of Internal Auditor of the Company for the F.Y. 2026-27;3. To consider the matters relating to the ensuing Annual General Meeting;4. Any other item may be taken up for consideration with the permission of the Chairman and with the consent of a majority of the Directors present in the Meeting which shall include at least one independent Director. If any
1 month ago
Choksi Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve 1. To consider and approve the Unaudited Financial Result of the Company for the Quarter ended on 30th June 2026;2. To consider the appointment of Internal Auditor of the Company for the F.Y. 2026-27;3. To consider the matters relating to the ensuing Annual General Meeting;4. Any other item may be taken up for consideration with the permission of the Chairman and with the consent of a majority of the Directors present in the Meeting which shall include at least one independent Director. If any
1 month ago
Newspaper publication of information regarding change of RTA
1 month ago
Newspaper publication of information regarding change of RTA
1 month ago
Intimation for change of RTA in pursuant to Regulation 30 of SEBI (LODR) 2015
1 month ago
Intimation for change of RTA in pursuant to Regulation 30 of SEBI (LODR) 2015
1 month ago
Submission of Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018
2 months ago
Submission of Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018
2 months ago
Intimation for Closure of trading window w.e.f. 01st July 2026
2 months ago
Intimation for Closure of trading window w.e.f. 01st July 2026
2 months ago
Submission of newspaper publication of financial result for the period ended 31.03.2026
3 months ago
Submission of newspaper publication of financial result for the period ended 31.03.2026
3 months ago
Submission of Annual Secretarial Compliance report under Regulation 24A issued by M/s Surabhi Agrawal & Associate for the year ended 31.03.2026
4 months ago
Result as attached
4 months ago
Result as attached
4 months ago
1. Considered and approved Audited Financial Results for the Quarter and Financial Year ended 31st March 2026 along with the along with the Auditors Report thereon Statement of Assets and Liabilities and Cash Flow Statement;2. Considered and approved the Annual Secretarial Compliance Report for the year ended 31st March 2025 as required under Regulation 24A of SEBI (LODR) 2015;3. Other routine businesses with the permission of chair.
4 months ago
1. Considered and approved Audited Financial Results for the Quarter and Financial Year ended 31st March 2026 along with the along with the Auditors Report thereon Statement of Assets and Liabilities and Cash Flow Statement;2. Considered and approved the Annual Secretarial Compliance Report for the year ended 31st March 2025 as required under Regulation 24A of SEBI (LODR) 2015;3. Other routine businesses with the permission of chair.
4 months ago
The clarification has been attached herewith in pursuant to additional details required for the corporate announcement filed under Regulation 30
4 months ago

Annual reports

FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21

Concalls & investor presentations

Empty box

No presentations found

Choksi Laboratories Ltd Share Price Today

The Choksi Laboratories Ltd share price today is ₹157.00. During the trading session, the Choksi Laboratories Ltd share price opened at ₹166.90 and recorded an intraday high of ₹169.75 and a low of ₹157.00. Last closing price was ₹165.25. Over the past 52 weeks, the Choksi Laboratories Ltd share price has ranged between ₹81.85 and ₹229.45. The current Choksi Laboratories Ltd stock price reflects real-time market activity based on executed trades on the exchange.